Rola eksemestanu w leczeniu raka piersi

Journal Title: OncoReview - Year 2012, Vol 2, Issue 4

Abstract

Leczenie hormonalne jest jedną z podstawowych opcji terapeutycznych w leczeniu raka piersi, zarówno miejscowo zaawansowanego, jak i przerzutowego. Standardem od wielu lat pozostaje tamoksyfen, jednak wyniki nowych badań klinicznych wskazują na inhibitory aromatazy jako na wartościową alternatywę w terapii pacjentek po menopauzie. Eksemestan jest steroidowym inhibitorem aromatazy, którego skuteczność została udowodniona na podstawie wyników badań omówionych w poniższym artykule.

Authors and Affiliations

Elżbieta Wójcik

Keywords

Related Articles

Cardioncology in Russia: Start-Off and Prospects

The progress in improving the survival of cancer patients in Russia, as well as throughout the world, means that in the next years it is going to be an increase in the number of disabled people who has achieved remission...

Complications of palliative antiangiogenic therapy in patients with colorectal cancer

Introduction: Bevacizumab is an antiangiogenic drug used in the therapy of numerous solid tumours including colorectal adenocarcinoma. The efficacy and safety of bevacizumab has been demonstrated in many multicenter clin...

Follicular mucinosis on the forehead of a 15-year-old girl

Follicular mucinosis is a rare dermatosis characterized by accumulation of mucin in the follicular epithelium and sebaceous glands. Clinically, it is characterized by the presence of papules or well-circumscribed and inf...

Distress and depression in cancer patients - diagnosis and treatment

Cancer diagnosis destroys previous internal and external order of patient, who has not experienced such a situation yet. The most negative emotions, which are felt in the situation of cancer diagnoses are anxiety, sadnes...

Effective treatment of severe hypertensive crisis in 2-year-old child with neuroblastoma

We describe a case of a 2-year-old boy with neuroblastoma and high catecholamine levels which developed a severe hypertensive crisis. An oral propranolol and oral angiotensin-converting enzyme inhibitor were used with a...

Download PDF file
  • EP ID EP53185
  • DOI -
  • Views 235
  • Downloads 0

How To Cite

Elżbieta Wójcik (2012). Rola eksemestanu w leczeniu raka piersi. OncoReview, 2(4), -. https://europub.co.uk/articles/-A-53185